Wako Pure Chemical to Market GNI's Pathway Software in Japan | GenomeWeb
NEW YORK (GenomeWeb News) – GNI, a drug-discovery firm based in Tokyo, has tapped Wako Pure Chemical to market its biopathway imaging and modeling software in Japan, GNI said last week.
 
Beginning in April, Wako will sell GNI’s Cell Illustrator software through its partner agencies in Japan.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

HHS Secretary Tom Price says the NIH budget contains unneeded expenses that can be trimmed, Stat News reports.

The chair of the House science committee says the journal Science is not objective, the Huffington Post reports.

In Nature this week: glioma GWAS uncovers new risk loci, and more.

Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.